Al Hammadi Company For Development and Investment
Market Cap
ر.س4.9b
Last Updated
2021/07/23 14:03 UTC
Data Sources
Company Financials +
Executive Summary
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. More Details
Rewards
Risk Analysis
No risks detected for 4007 from our risk checks.
Snowflake Analysis
Flawless balance sheet with solid track record.
Similar Companies
Share Price & News
How has Al Hammadi Company For Development and Investment's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4007 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 4007's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
0%
4007
0%
SA Healthcare
0%
SA Market
1 Year Return
57.4%
4007
75.1%
SA Healthcare
14.6%
SA Market
Return vs Industry: 4007 underperformed the SA Healthcare industry which returned 75.1% over the past year.
Return vs Market: 4007 exceeded the SA Market which returned 14.6% over the past year.
Shareholder returns
| 4007 | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | 0% | 0% |
| 30 Day | 5.5% | -1.7% | -1.1% |
| 90 Day | 24.5% | 14.5% | 0.5% |
| 1 Year | 59.7%57.4% | 78.0%75.1% | 19.0%14.6% |
| 3 Year | 26.9%25.0% | 45.1%38.8% | 38.7%25.8% |
| 5 Year | 8.8%5.1% | 56.4%43.8% | 99.6%69.1% |
Long-Term Price Volatility Vs. Market
How volatile is Al Hammadi Company For Development and Investment's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
The Returns At Al Hammadi Company For Development and Investment (TADAWUL:4007) Aren't GrowingValuation
Is Al Hammadi Company For Development and Investment undervalued compared to its fair value and its price relative to the market?
15.3%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 4007 (SAR40.45) is trading below our estimate of fair value (SAR47.78)
Significantly Below Fair Value: 4007 is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: 4007 is good value based on its PE Ratio (34.3x) compared to the SA Healthcare industry average (41x).
PE vs Market: 4007's PE Ratio (34.3x) is in line with the SA market.
Price to Earnings Growth Ratio
PEG Ratio: 4007 is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: 4007's PB Ratio (2.9x) is in line with the SA Healthcare industry average.
Future Growth
How is Al Hammadi Company For Development and Investment forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
15.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4007's forecast earnings growth (15.9% per year) is above the savings rate (8.8%).
Earnings vs Market: 4007's earnings (15.9% per year) are forecast to grow faster than the SA market (7.7% per year).
High Growth Earnings: 4007's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4007's revenue (7.1% per year) is forecast to grow faster than the SA market (3.7% per year).
High Growth Revenue: 4007's revenue (7.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4007's Return on Equity is forecast to be low in 3 years time (13.5%).
Past Performance
How has Al Hammadi Company For Development and Investment performed over the past 5 years?
4.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4007 has high quality earnings.
Growing Profit Margin: 4007's current net profit margins (13.3%) are higher than last year (9.9%).
Past Earnings Growth Analysis
Earnings Trend: 4007's earnings have grown by 4.7% per year over the past 5 years.
Accelerating Growth: 4007's earnings growth over the past year (50.8%) exceeds its 5-year average (4.7% per year).
Earnings vs Industry: 4007 earnings growth over the past year (50.8%) exceeded the Healthcare industry 23.8%.
Return on Equity
High ROE: 4007's Return on Equity (8.4%) is considered low.
Financial Health
How is Al Hammadi Company For Development and Investment's financial position?
Financial Position Analysis
Short Term Liabilities: 4007's short term assets (SAR796.6M) exceed its short term liabilities (SAR415.1M).
Long Term Liabilities: 4007's short term assets (SAR796.6M) exceed its long term liabilities (SAR405.1M).
Debt to Equity History and Analysis
Debt Level: 4007's debt to equity ratio (15.6%) is considered satisfactory.
Reducing Debt: 4007's debt to equity ratio has reduced from 39.3% to 15.6% over the past 5 years.
Debt Coverage: 4007's debt is well covered by operating cash flow (100.4%).
Interest Coverage: 4007's interest payments on its debt are well covered by EBIT (9.4x coverage).
Balance Sheet
Dividend
What is Al Hammadi Company For Development and Investment current dividend yield, its reliability and sustainability?
1.24%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4007's dividend (1.24%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.47%).
High Dividend: 4007's dividend (1.24%) is low compared to the top 25% of dividend payers in the SA market (4.5%).
Stability and Growth of Payments
Stable Dividend: 4007 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4007 has only been paying a dividend for 6 years, and since then payments have fallen.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.4%), 4007's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 4007's dividends in 3 years are forecast to be covered by earnings (74.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.8yrs
Average board tenure
CEO
Mohammad Bin Saleh Al Hammadi (50 yo)
25.5yrs
Tenure
Mr. Mohammad Bin Saleh Al Hammadi serves as an Executive Director & Managing Director at Al Hammadi Development and Investment Company. He has been an Owner of Al Hammadi Information Technology Establishme...
Board Members
Experienced Board: 4007's board of directors are considered experienced (5.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Al Hammadi Company For Development and Investment's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Al Hammadi Company For Development and Investment
- Ticker: 4007
- Exchange: SASE
- Founded: 1985
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ر.س4.854b
- Shares outstanding: 120.00m
- Website: https://www.alhammadi.com
Location
- Al Hammadi Company For Development and Investment
- PO Box 55004
- PO Box 55004
- Riyadh
- 11534
- Saudi Arabia
Listings
Biography
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services a...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/07/23 14:03 |
| End of Day Share Price | 2021/07/15 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.